Intranasal Corticosteroids Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Prescribed Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Intranasal Corticosteroids Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Intranasal Corticosteroids Market Perspective (2017-2028)
2.2 Intranasal Corticosteroids Growth Trends by Region
2.2.1 Intranasal Corticosteroids Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Intranasal Corticosteroids Historic Market Size by Region (2017-2022)
2.2.3 Intranasal Corticosteroids Forecasted Market Size by Region (2023-2028)
2.3 Intranasal Corticosteroids Market Dynamics
2.3.1 Intranasal Corticosteroids Industry Trends
2.3.2 Intranasal Corticosteroids Market Drivers
2.3.3 Intranasal Corticosteroids Market Challenges
2.3.4 Intranasal Corticosteroids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intranasal Corticosteroids Players by Revenue
3.1.1 Global Top Intranasal Corticosteroids Players by Revenue (2017-2022)
3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2017-2022)
3.2 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intranasal Corticosteroids Revenue
3.4 Global Intranasal Corticosteroids Market Concentration Ratio
3.4.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2021
3.5 Intranasal Corticosteroids Key Players Head office and Area Served
3.6 Key Players Intranasal Corticosteroids Product Solution and Service
3.7 Date of Enter into Intranasal Corticosteroids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intranasal Corticosteroids Breakdown Data by Type
4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2017-2022)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2023-2028)
5 Intranasal Corticosteroids Breakdown Data by Application
5.1 Global Intranasal Corticosteroids Historic Market Size by Application (2017-2022)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Intranasal Corticosteroids Market Size (2017-2028)
6.2 North America Intranasal Corticosteroids Market Size by Country (2017-2022)
6.3 North America Intranasal Corticosteroids Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Intranasal Corticosteroids Market Size (2017-2028)
7.2 Europe Intranasal Corticosteroids Market Size by Country (2017-2022)
7.3 Europe Intranasal Corticosteroids Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intranasal Corticosteroids Market Size (2017-2028)
8.2 Asia-Pacific Intranasal Corticosteroids Market Size by Country (2017-2022)
8.3 Asia-Pacific Intranasal Corticosteroids Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Intranasal Corticosteroids Market Size (2017-2028)
9.2 Latin America Intranasal Corticosteroids Market Size by Country (2017-2022)
9.3 Latin America Intranasal Corticosteroids Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intranasal Corticosteroids Market Size (2017-2028)
10.2 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2017-2022)
10.3 Middle East & Africa Intranasal Corticosteroids Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
11.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Intranasal Corticosteroids Introduction
11.2.4 Merck Revenue in Intranasal Corticosteroids Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Intranasal Corticosteroids Introduction
11.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2017-2022)
11.3.5 Sanofi Recent Development
11.4 SUMITOMO
11.4.1 SUMITOMO Company Detail
11.4.2 SUMITOMO Business Overview
11.4.3 SUMITOMO Intranasal Corticosteroids Introduction
11.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2017-2022)
11.4.5 SUMITOMO Recent Development
11.5 Teva
11.5.1 Teva Company Detail
11.5.2 Teva Business Overview
11.5.3 Teva Intranasal Corticosteroids Introduction
11.5.4 Teva Revenue in Intranasal Corticosteroids Business (2017-2022)
11.5.5 Teva Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
11.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Intranasal Corticosteroids Introduction
11.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2017-2022)
11.7.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Prescribed Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Intranasal Corticosteroids Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Intranasal Corticosteroids Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Intranasal Corticosteroids Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Intranasal Corticosteroids Market Share by Region (2017-2022)
Table 8. Global Intranasal Corticosteroids Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Intranasal Corticosteroids Market Share by Region (2023-2028)
Table 10. Intranasal Corticosteroids Market Trends
Table 11. Intranasal Corticosteroids Market Drivers
Table 12. Intranasal Corticosteroids Market Challenges
Table 13. Intranasal Corticosteroids Market Restraints
Table 14. Global Intranasal Corticosteroids Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Intranasal Corticosteroids Market Share by Players (2017-2022)
Table 16. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2021)
Table 17. Ranking of Global Top Intranasal Corticosteroids Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Intranasal Corticosteroids Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intranasal Corticosteroids Product Solution and Service
Table 21. Date of Enter into Intranasal Corticosteroids Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intranasal Corticosteroids Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Intranasal Corticosteroids Revenue Market Share by Type (2017-2022)
Table 25. Global Intranasal Corticosteroids Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Intranasal Corticosteroids Revenue Market Share by Type (2023-2028)
Table 27. Global Intranasal Corticosteroids Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Intranasal Corticosteroids Revenue Market Share by Application (2017-2022)
Table 29. Global Intranasal Corticosteroids Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Intranasal Corticosteroids Revenue Market Share by Application (2023-2028)
Table 31. North America Intranasal Corticosteroids Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Intranasal Corticosteroids Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Intranasal Corticosteroids Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Intranasal Corticosteroids Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Intranasal Corticosteroids Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Intranasal Corticosteroids Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Intranasal Corticosteroids Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Intranasal Corticosteroids Market Size by Country (2023-2028) & (US$ Million)
Table 41. GlaxoSmithKline Company Detail
Table 42. GlaxoSmithKline Business Overview
Table 43. GlaxoSmithKline Intranasal Corticosteroids Product
Table 44. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 45. GlaxoSmithKline Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Intranasal Corticosteroids Product
Table 49. Merck Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Intranasal Corticosteroids Product
Table 54. Sanofi Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. SUMITOMO Company Detail
Table 57. SUMITOMO Business Overview
Table 58. SUMITOMO Intranasal Corticosteroids Product
Table 59. SUMITOMO Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 60. SUMITOMO Recent Development
Table 61. Teva Company Detail
Table 62. Teva Business Overview
Table 63. Teva Intranasal Corticosteroids Product
Table 64. Teva Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 65. Teva Recent Development
Table 66. Johnson & Johnson Company Detail
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Intranasal Corticosteroids Product
Table 69. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Intranasal Corticosteroids Product
Table 74. AstraZeneca Revenue in Intranasal Corticosteroids Business (2017-2022) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intranasal Corticosteroids Market Share by Type: 2021 VS 2028
Figure 2. Prescribed Drugs Features
Figure 3. OTC Drugs Features
Figure 4. Global Intranasal Corticosteroids Market Share by Application in 2021 & 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharnacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Intranasal Corticosteroids Report Years Considered
Figure 9. Global Intranasal Corticosteroids Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Intranasal Corticosteroids Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Intranasal Corticosteroids Market Share by Region: 2021 VS 2028
Figure 12. Global Intranasal Corticosteroids Market Share by Players in 2021
Figure 13. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2021
Figure 15. North America Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Intranasal Corticosteroids Market Share by Country (2017-2028)
Figure 17. United States Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Intranasal Corticosteroids Market Share by Country (2017-2028)
Figure 21. Germany Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Intranasal Corticosteroids Market Share by Region (2017-2028)
Figure 29. China Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Intranasal Corticosteroids Market Share by Country (2017-2028)
Figure 37. Mexico Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Intranasal Corticosteroids Market Share by Country (2017-2028)
Figure 41. Turkey Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Intranasal Corticosteroids Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 44. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 45. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 46. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 47. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 48. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 49. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Industry Market Size
